LHC Group (NASDAQ:LHCG) – Analysts at SunTrust Banks lifted their Q3 2017 EPS estimates for LHC Group in a research report issued on Thursday. SunTrust Banks analyst D. Macdonald now anticipates that the health services provider will post earnings of $0.59 per share for the quarter, up from their prior estimate of $0.57. SunTrust Banks also issued estimates for LHC Group’s Q4 2017 earnings at $0.63 EPS, FY2017 earnings at $2.38 EPS, Q1 2018 earnings at $0.59 EPS, Q2 2018 earnings at $0.69 EPS, Q3 2018 earnings at $0.64 EPS, FY2018 earnings at $2.62 EPS and FY2019 earnings at $2.88 EPS.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, topping the consensus estimate of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The firm had revenue of $260.20 million for the quarter, compared to the consensus estimate of $254.10 million. During the same quarter last year, the company earned $0.52 earnings per share. The business’s revenue for the quarter was up 15.1% compared to the same quarter last year. TRADEMARK VIOLATION NOTICE: “Q3 2017 EPS Estimates for LHC Group Raised by SunTrust Banks (LHCG)” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/19/q3-2017-eps-estimates-for-lhc-group-raised-by-suntrust-banks-lhcg-updated.html.

LHCG has been the subject of several other research reports. Royal Bank Of Canada reissued a “buy” rating and issued a $69.00 price objective on shares of LHC Group in a report on Friday, May 5th. Benchmark Co. boosted their price objective on LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, June 8th. Zacks Investment Research raised LHC Group from a “hold” rating to a “buy” rating and set a $59.00 price objective for the company in a report on Wednesday, April 19th. Jefferies Group LLC reissued a “buy” rating and issued a $65.00 price objective (up previously from $56.00) on shares of LHC Group in a report on Friday, May 5th. Finally, BidaskClub cut LHC Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. LHC Group has an average rating of “Buy” and an average target price of $65.75.

LHC Group (NASDAQ LHCG) opened at 63.95 on Monday. The company has a market cap of $1.13 billion, a P/E ratio of 28.30 and a beta of 0.77. The stock has a 50 day moving average price of $64.12 and a 200 day moving average price of $56.24. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35.

In related news, COO Donald Dwayne Stelly sold 3,181 shares of the company’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the completion of the transaction, the chief operating officer now owns 114,235 shares of the company’s stock, valued at approximately $7,421,847.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Coliseum Capital Management, L sold 14,450 shares of the company’s stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $65.69, for a total value of $949,220.50. The disclosure for this sale can be found here. Insiders sold a total of 682,839 shares of company stock valued at $42,140,531 in the last ninety days. 14.80% of the stock is currently owned by insiders.

Institutional investors have recently added to or reduced their stakes in the company. Principal Financial Group Inc. boosted its position in LHC Group by 9.2% in the second quarter. Principal Financial Group Inc. now owns 124,138 shares of the health services provider’s stock worth $8,427,000 after buying an additional 10,431 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its position in LHC Group by 34.0% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 10,552 shares of the health services provider’s stock worth $716,000 after buying an additional 2,675 shares during the last quarter. Royce & Associates LP acquired a new position in LHC Group during the second quarter worth $1,018,000. Great Lakes Advisors LLC boosted its position in LHC Group by 20.4% in the second quarter. Great Lakes Advisors LLC now owns 34,840 shares of the health services provider’s stock worth $2,365,000 after buying an additional 5,908 shares during the last quarter. Finally, Bridge City Capital LLC acquired a new position in LHC Group during the second quarter worth $1,267,000. 84.97% of the stock is owned by institutional investors.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.